Groowe Groowe / Newsroom / MRK
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

MRK News

Merck & Co., Inc.

Pimicotinib Approved as Systemic Treatment in China for Tenosynovial Giant Cell Tumor

businesswire.com
MRK

Merck Reaches Agreement With U.S. Government to Expand Access to Medicines and Lower Costs for Americans

businesswire.com
MRK

Evaxion provides update on MSD collaboration - retains global rights to Gonorrhea vaccine candidate EVX-B2

globenewswire.com
EVAX MRK

MMA Announces SMARTIES™ X Global 2025 Winners: Honoring Marketing That Drives Global Impact USA - English India - English APAC - English

prnewswire.com
ADBE AMZN T BAC BCG CPB DAL DIS LLY XOM F GM GOOG HRL HSY HLT HD IPG JPM K KR LINK MAR MA MCD MRK META MSFT MOS MS NFLX PINS PPG PRG ROKU CRM SMG SNA SFTBY TGT TTD TMUS TU UBER UL V WMT

Pyxis Oncology Announces Positive Preliminary Phase 1 Data for Micvotabart Pelidotin (MICVO) in Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma

globenewswire.com
PYXS MRK

Ulcerative Colitis Market Poised for Strong Expansion During the Forecast Period (2025-2034) Driven by Biologic and Novel Therapy Adoption Landscape | DelveInsight

prnewswire.com
ABBV JNJ LLY MRK PFE ABVX

BTK Inhibitors Clinical Trial Pipeline Accelerates as 30+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

globenewswire.com
PFE SNY TSEM JNJ LLY MRK BMY ABBV GILD CRSP NKTR INCY

Breast Cancer Drugs Market to Reach USD 57.1 Billion by 2031 as Precision Oncology and Targeted Therapies Redefine Treatment Outcomes

prnewswire.com
NVS LLY AZN MRK ABBV BMED MGNX

Antibody Optimization Service Market Set to Reach USD 6.07 Billion by 2034, Growing at an 8.45% CAGR Amid Advances in Gene-Editing Technologies

globenewswire.com
ABBV BMY GILD AMGN AZN LLY BIIB REGN VRTX XBI IBB CRSP EDIT NTLA ABCL NVS MRK PFE JNJ GSK SNY BTAI INSM

KEYTRUDA ® (pembrolizumab) Plus Padcev ® (enfortumab vedotin-ejfv) Significantly Improved Event-Free Survival, Overall Survival and Pathologic Complete Response Rates for Cisplatin-Eligible Patients with MIBC When Given Before and After Surgery

businesswire.com
MRK